Year: 2022
Type: dissertation
Abstract: Under physiological conditions, apoptosis is a cellular mechanism triggered when the cell is damaged and leads to cell suicide orchestrated by caspases, which form a family of proteases that control the process of cell death. In certain conditions, such as in cancer where there is resistance to cell death, it has long been thought that caspase activity is near completely suppressed. However, initiator caspase-8 is activated in colorectal cancer (CRC) cells in the absence of apoptosis. This raises questions about its canonical role, which is intended to be pro-apoptotic. Among the proteins that are cleaved by initiator caspases in CRC cells, our laboratory has identified SNX1 and SNX2. These two proteins are involved in the intracellular routing and signaling of receptor tyrosine kinase, which are involved in the pathogenesis of CRC. This project aims at identifying other proteins such as SNX1 and SNX2 that are cleaved by initiator caspases and which could increase tumorigenicity and the ability to metastasize. Our research hypothesis is that caspase-8 and -10 has other substrates which, upon cleavage in cells resistant to apoptosis of CRC, would increase the tumorigenicity and metastatic capacity of cancer cells. Our goal was to identify new substrates and to characterize the impact of their cleavage on cancer tumorigenicity. We first made HCT-116 cells resistant to apoptosis. To achieve this, several approaches were attempted such as the reduction of pro-apoptotic proteins and the increase of anti-apoptotic proteins expression, without success. However, we succeeded by completely removing using CRISPR-Cas9, the executioner caspases 3 and 7. We demonstrated that the cells were resistant by various tests including following the induction of apoptosis with TRAIL and by observing PARP-1 cleavage, a marker of apoptosis. To identify substrates, we labeled resistant cells with isotopes (SILAC) and induced cell death in them. We analyzed the results by mass spectrometry and identified a potential substrate, profilin-1. However, we could not confirm its cleavage by immunoblotting. We attempted the same procedure, but using the TAILS proteomics technique, without obtaining any substrate. Therefore, our hypothesis remains to be verified. It would be interesting to try other proteomic methods or to optimize them to be able to identify new substrates. Nevertheless, the cellular model we developed constitute a very useful tool to investigate initiator caspase substrates.
Author: Létourneau, Victor
Institution: Université de Sherbrooke
Language: French
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7201942123
